ecrin-mdr-crcClinical2016Lymphoma, Mantle-CellColorectal CancerMantle Cell LymphomaAdvanced CancerNeoplasmsColorectal CancerMantle Cell LymphomaAdvanced CancerLymphoma, Mantle-cellNeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2213121United StatesUnited KingdomFrance10RamucirumabECRIN MDRCompletedfalseA Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted AgentsThe main purpose of this study is to evaluate the safety of ramucirumab in combination with other targeted agents in participants with advanced cancers.2016-10-152213121NCT027457692015-004381-28